| SC 13G/A | 2024-02-14 | Cormorant Asset Management, LP | Korro Bio, Inc. | 312,052 | - | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Korro Bio, Inc. | - | 6.6% | EDGAR |
| SC 13G | 2024-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | Korro Bio, Inc. | 546,325 | 6.8% | EDGAR |
| SC 13G | 2024-02-09 | FMR LLC | Korro Bio, Inc. | 727,205 | 9.1% | EDGAR |
| SC 13D | 2023-11-17 | New Enterprise Associates 17, L.P. | Korro Bio, Inc. | 1,072,936 | 13.4% | EDGAR |
| SC 13G | 2023-11-17 | Platanus Investment LLC | Korro Bio, Inc. | 540,165 | 6.8% | EDGAR |
| SC 13G | 2023-11-16 | Cormorant Asset Management, LP | Korro Bio, Inc. | 462,052 | - | EDGAR |
| SC 13D | 2023-11-13 | Atlas Venture Fund XI, L.P. | Korro Bio, Inc. | 942,075 | 11.8% | EDGAR |
| SC 13G | 2023-11-13 | CITADEL ADVISORS LLC | Korro Bio, Inc. | - | 6.8% | EDGAR |
| SC 13G | 2023-11-13 | Artal International S.C.A. | Korro Bio, Inc. | 418,605 | 5.2% | EDGAR |
| SC 13G | 2023-11-09 | Point72 Asset Management, L.P. | Korro Bio, Inc. | 265,826 | 3.3% | EDGAR |
| SC 13G | 2023-10-12 | Lucchino David L. | Frequency Therapeutics, Inc. | 2,368,527 | 6.2% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Frequency Therapeutics, Inc. | 1,737,306 | 5.0% | EDGAR |
| SC 13G/A | 2022-06-10 | FEDERATED HERMES, INC. | Frequency Therapeutics, Inc. | 1,552,239 | 4.4% | EDGAR |
| SC 13G/A | 2022-06-06 | WASATCH ADVISORS INC | Frequency Therapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | Frequency Therapeutics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | FEDERATED HERMES, INC. | Frequency Therapeutics, Inc. | 2,801,066 | 8.1% | EDGAR |
| SC 13G/A | 2022-02-11 | WASATCH ADVISORS INC | Frequency Therapeutics, Inc. | - | - | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Frequency Therapeutics, Inc. | 3,044,997 | 8.8% | EDGAR |
| SC 13G/A | 2021-04-09 | FEDERATED HERMES, INC. | Frequency Therapeutics, Inc. | 3,601,272 | 10.5% | EDGAR |